
    
      All participants will receive a single dose of their assigned vaccine on Day 0. A subset of
      the participants will be assessed for immunologic response on Day 0 before vaccination and
      Day 28 after vaccination. All subjects will be monitored for safety for up to 6 months after
      vaccination.
    
  